Wentworth Kory James
Entrada Therapeutics, Inc. · Chief Financial Officer
Wentworth Kory James is listed in filings as Chief Financial Officer at Entrada Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 2, 2026, including sale activity. Recent filings connect the profile to Entrada Therapeutics, Inc. (TRDA). The current snapshot covers public activity from Jul 10, 2024 to Apr 2, 2026. Reported amounts are shown as $32.4K to $66.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $148k11.4k shares | SellMar 10, 2026 | $13.02 | $6.73 | |
| $66k5.1k shares | SellMar 9, 2026 | $13.00 | $6.73 | |
| $98k8k shares | SellMar 4, 2026 | $12.25 | $6.73 | |
| $89k8.9k shares | SellNov 21, 2025 | $9.98 | $6.73 | |
| $19k1.8k shares | SellMar 17, 2025 | $10.67 | $6.73 | |
| $100k5k shares | SellDec 2, 2024 | $20.00 | $6.73 | |
| $20k1k shares | SellNov 29, 2024 | $19.97 | $6.73 | |
| $173k8.6k shares | SellNov 11, 2024 | $19.98 | $6.73 | |
| $48k3.2k shares | SellSep 9, 2024 | $14.97 | $6.73 | |
| $26k1.8k shares | SellJul 8, 2024 | $14.95 | $6.73 |